Published in EGEMS (Wash DC) on January 01, 2013
Making sense of the shadows: priorities for creating a learning healthcare system based on routinely collected data. BMJ Qual Saf (2015) 0.81
Linking electronic health records to better understand breast cancer patient pathways within and between two health systems. EGEMS (Wash DC) (2015) 0.79
Ethnicity and cardiovascular health inequalities in people with severe mental illnesses: protocol for the E-CHASM study. Soc Psychiatry Psychiatr Epidemiol (2016) 0.77
Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA (1994) 11.32
Matching methods for causal inference: A review and a look forward. Stat Sci (2010) 9.78
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40
Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology (2008) 6.87
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol (2003) 5.81
Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health (1998) 5.55
Standards of evidence: criteria for efficacy, effectiveness and dissemination. Prev Sci (2005) 5.52
Improving propensity score weighting using machine learning. Stat Med (2010) 4.22
Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Stat Med (2002) 4.15
Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research. Psychol Methods (2010) 2.99
Caveats for the use of operational electronic health record data in comparative effectiveness research. Med Care (2013) 2.89
Alternatives to the randomized controlled trial. Am J Public Health (2008) 2.85
Value-based purchasing--national programs to move from volume to value. N Engl J Med (2012) 2.11
Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. J Clin Epidemiol (2009) 1.73
The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis. Acta Diabetol (2009) 1.69
Effect of the 2010 Chilean earthquake on posttraumatic stress: reducing sensitivity to unmeasured bias through study design. Epidemiology (2013) 1.58
Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. J Clin Epidemiol (2009) 1.56
Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease. Stat Methods Med Res (2011) 1.49
Do new prescription drugs pay for themselves? The case of second-generation antipsychotics. J Health Econ (2005) 1.44
Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS). Pharmacoepidemiol Drug Saf (2009) 1.39
The importance of covariate selection in controlling for selection bias in observational studies. Psychol Methods (2010) 1.32
Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev (2001) 1.28
Confounding adjustment in comparative effectiveness research conducted within distributed research networks. Med Care (2013) 1.23
Single port access laparoscopic adnexal surgery versus conventional laparoscopic adnexal surgery: a comparison of peri-operative outcomes. Eur J Obstet Gynecol Reprod Biol (2010) 1.19
Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis. Diabetes Obes Metab (2012) 1.05
Effect of a UK pay-for-performance program on ethnic disparities in diabetes outcomes: interrupted time series analysis. Ann Fam Med (2012) 1.04
Implications of Part D for mentally ill dual eligibles: a challenge for Medicare. Health Aff (Millwood) (2006) 1.02
The importance of clinical variables in comparative analyses using propensity-score matching: the case of ESA costs for the treatment of chemotherapy-induced anaemia. Pharmacoeconomics (2009) 0.97
An introduction to sensitivity analysis for unobserved confounding in nonexperimental prevention research. Prev Sci (2013) 0.87
Analysis of treatment effectiveness in longitudinal observational data. J Biopharm Stat (2007) 0.84